ALIGOS THERAPEUTICS INC (ALGS:NASDAQ)
$8.47 0.475 (5.9412%)
Analysed ALIGOS THERAPEUTICS INC (ALGS:NASDAQ) News Sources
Aligos Therapeutics Reports Recent Business Progress and Fourth Quarter and Full Year 2025 Financial Results
05-03-2026
yahoo.com
Aligos Therapeutics to Announce 4th Quarter 2025 Financial Results on March 5, 2026
26-02-2026
yahoo.com
Aligos Therapeutics Presents Positive Data at the Conference on Retroviruses and Opportunistic Infections (CROI)
23-02-2026
yahoo.com
Aligos Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
30-01-2026
yahoo.com
Aligos Therapeutics Provides Phase 2 B-SUPREME Study Progress Updates
21-01-2026
yahoo.com
Aligos Therapeutics Strengthens Senior Leadership Team with the Appointment of James Hassard as Executive Vice President, Chief Commercial Officer
13-01-2026
yahoo.com
Onco3R Therapeutics Appoints Lawrence Blatt as Chair of the Board for Onco3R Therapeutics
08-01-2026
yahoo.com
Here's Why Aligos Therapeutics (NASDAQ:ALGS) Must Use Its Cash Wisely
07-01-2026
yahoo.com
Aligos Therapeutics Presents Positive Data at HEP-DART 2025
11-12-2025
yahoo.com
Aligos Therapeutics Presents Positive Data at The Liver Meeting® 2025
10-11-2025
yahoo.com
What is the current price of ALIGOS THERAPEUTICS INC (ALGS:NASDAQ)?
The current price of ALIGOS THERAPEUTICS INC (ALGS:NASDAQ) is $8.47.
ALIGOS THERAPEUTICS INC (ALGS:NASDAQ) absolute price change since previous trading day?
The absolute price change of ALIGOS THERAPEUTICS INC (ALGS:NASDAQ) since the previous trading day is $0.475.
ALIGOS THERAPEUTICS INC (ALGS:NASDAQ) percentage price change since previous trading day?
The percentage price change of ALIGOS THERAPEUTICS INC (ALGS:NASDAQ) since the previous trading day is 5.9412%.
What is the most recent average sentiment score for ALIGOS THERAPEUTICS INC (ALGS:NASDAQ)?
The most recent average sentiment score for ALIGOS THERAPEUTICS INC (ALGS:NASDAQ) is 88 out of 100.
What is the most recent average sentiment for ALIGOS THERAPEUTICS INC (ALGS:NASDAQ)?
The most recent sentiment for ALIGOS THERAPEUTICS INC (ALGS:NASDAQ) is .
SEC-8K** Filing Available For ALIGOS THERAPEUTICS INC (ALGS:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.